Design and synthesis of dual ALK/BRD4 inhibitors

被引：0
|
作者：
Watts, Ellen [1 ]
Tucker, Elizabeth [2 ]
Heidenreich, David [3 ]
Bellenie, Benjamin [1 ]
Knapp, Stefan [3 ,4 ]
Chesler, Louis [2 ]
Hoelder, Swen [1 ]
机构：
[1] Inst Canc Res, Div Canc Therapeut, London, England
[2] Inst Canc Res, Paediat Solid Tumour Biol & Therapeut Team, London, England
[3] Goethe Univ Frankfurt, Frankfurt, Germany
[4] Struct Genom Consortium, Oxford, England
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2018年 / 255卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
63
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Synthesis and Biological Activity of Quinoxalone Derivatives as BRD4 Bromodomain Inhibitors
    Xu, Bin
    Zhao, Lei-Lei
    Yang, Yi-Fei
    Zhang, Jian
    Yang, Ling-Yun
    Zhang, Bing
    Han, Li
    Zhang, Hui-Bin
    Zhou, Jin-Pei
    [J]. LETTERS IN DRUG DESIGN & DISCOVERY, 2017, 14 (01) : 50 - 57
  • [22] BRD4 inhibitors block telomere elongation
    Wang, Steven
    Pike, Alexandra M.
    Lee, Stella S.
    Strong, Margaret A.
    Connelly, Carla J.
    Greider, Carol W.
    [J]. NUCLEIC ACIDS RESEARCH, 2017, 45 (14) : 8403 - 8410
  • [23] Review on: BRD4 inhibitors for anticancer research
    Singh, Vindhya Vikram
    Alauddin, Shafqat
    [J]. HUMAN GENE, 2023, 37
  • [24] An Overview on Small Molecule Inhibitors of BRD4
    Huang, Wenhai
    Zheng, Xiaoliang
    Yang, Yewei
    Wang, Xiaoju
    Shen, Zhengrong
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2016, 16 (17) : 1403 - 1414
  • [25] Design, synthesis and biological evaluation of novel indole derivatives as potential HDAC/BRD4 dual inhibitors and anti-leukemia agents
    Cheng, Gaoliang
    Wang, Zhi
    Yang, Jinyu
    Bao, Yu
    Xu, Qihao
    Zhao, Linxiang
    Liu, Dan
    [J]. BIOORGANIC CHEMISTRY, 2019, 84 : 410 - 417
  • [26] Design, synthesis and biological evaluation of indole-2-one derivatives as potent BRD4 inhibitors
    Xu, Yu
    Zhang, Xiu-Juan
    Li, Wen-Bo
    Wang, Xing-Rong
    Wang, Shuai
    Qiao, Xue-Peng
    Chen, Shi-Wu
    [J]. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2020, 208
  • [27] Design, Synthesis, and in vitro Biological Evaluation of 3,5-Dimethylisoxazole Derivatives as BRD4 Inhibitors
    Li, Xiangyang
    Zhang, Jian
    Zhao, Leilei
    Yang, Yifei
    Zhang, Huibin
    Zhou, Jinpei
    [J]. CHEMMEDCHEM, 2018, 13 (13) : 1363 - 1368
  • [28] Design, synthesis and biological evaluation of 3,5-dimethylisoxazole and pyridone derivatives as BRD4 inhibitors
    Rong, Juan
    Feng, Zhan-Zhan
    Shi, Yao-Jie
    Ren, Jing
    Xu, Ying
    Wang, Ning-Yu
    Xue, Qiang
    Liu, Kun-Lin
    Zhou, Shu-Yan
    Wei, Wei
    Yu, Luo-Ting
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2019, 29 (19)
  • [29] Dual-target Inhibitors Based on BRD4: Novel Therapeutic Approaches for Cancer
    Zhang, Sitao
    Chen, Yanzhao
    Tian, Chengsen
    He, Yujing
    Tian, Zeru
    Wan, Yichao
    Liu, Tingting
    [J]. CURRENT MEDICINAL CHEMISTRY, 2021, 28 (09) : 1775 - 1795
  • [30] BRD4 Degradation By Protacs Represents a More Effective Therapeutic Strategy Than BRD4 Inhibitors in DLBCL
    Lu, Jing
    Qian, Yimin
    Raina, Kanak
    Altieri, Martha
    Dong, Hanqing
    Wang, Jing
    Chen, Xin
    Crew, Andrew
    Coleman, Kevin
    Crews, Craig
    Winkler, James
    [J]. BLOOD, 2015, 126 (23)
12345